MENU

IVA Inventiva SA Forecast, Technical & Fundamental Analysis

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IVA is expected to report earnings to fall 43.42% to -43 cents per share on March 26

Inventiva SA IVA Stock Earnings Reports
Q4'24
Est.
$-0.43
Q3'24
Missed
by $0.20
Q2'24
Missed
by $0.17
Q1'24
Beat
by $0.04
Q4'23
Beat
by $0.04
The last earnings report on November 21 showed earnings per share of -75 cents, missing the estimate of -56 cents. With 22.77K shares outstanding, the current market capitalization sits at 118.15M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 rue de Dijon
Phone
+33 380447500
Employees
123
Web
https://www.inventivapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

IVA and Stocks

Correlation & Price change

A.I.dvisor tells us that IVA and TVGN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVA and TVGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVA
1D Price
Change %
IVA100%
-4.54%
TVGN - IVA
28%
Poorly correlated
-5.88%
CUE - IVA
24%
Poorly correlated
+3.92%
VRCA - IVA
24%
Poorly correlated
-2.51%
IMMP - IVA
23%
Poorly correlated
+2.40%
MRNA - IVA
23%
Poorly correlated
-2.58%
More